Ainos (AIMD) said Monday it was granted an invention patent in Japan for its oral interferon formulation Veldona to treat and prevent coronavirus infections.
The new patent includes 15 claims covering Veldona's formulation, delivery mechanisms, and therapeutic applications, the company said.
The Japan approval follows a recent patent approval in Taiwan, Ainos said.
Shares of Ainos were down more than 4% in recent trading.
Price: 0.77, Change: -0.03, Percent Change: -4.26
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.